-
-
For unknown reasons, adenocarcinoma of the esophagus (E-ca) is experiencing the most rapid increase of any known cancer in the United States.
-
Rivaroxaban, an oral factor XA inhibitor, has been approved for reducing the risk of stroke in patients with atrial fibrillation (AF). The drug joins dabigatran (Pradaxa) as the second "nonwarfarin" oral anticoagulant approved for this indication.
-
Eating chocolate may be part of a healthy lifestyle.
-
Interpret the rhythm for the 12-lead ECG and lead II rhythm strip shown above. The patient was aware of "rapid heart beat" but was hemodynamically stable at the time the tracing was recorded. What is your differential diagnosis? What diagnostic maneuver might help to determine what the rhythm is?
-
Dihydroergotamine, in a longer 5-day intravenous protocol for refractory primary headache appears to be efficacious, but this older medication needs to be compared directly to newer migraine treatments.
-
New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions.
-
-
Based on a retrospective study of 34 patients, the authors report that clinical manifestations of brain involvement are not uncommon in the neuromyelitis optica spectrum of disorders.
-
Spreading depolarisations following severe traumatic brain injury are associated with a poor outcome. They serve to cause secondary injury and energy imbalance. This mechanism might provide a target for therapeutic intervention.